Searched for
INSULIN DISCOVERY
In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
Blood Sugar treatment: Type 2 diabetes can be countered by natural compound, claim international group of scientists in studyType 2 diabetes treatment: The findings suggest that TMA may help recalibrate harmful metabolic responses triggered by poor dietary habits.
Diabetes new type emerges after type 2, type 1 as medical experts are calling it type 5, over 25 million people suffer. Symptoms, treatment, illnessDiabetes type 2, can be caused by obesity and occurs when adults become resistant to the hormone insulin. Type 1 diabetes, mostly diagnosed...
Cure for Type 1 diabetes? Cancer research accidentally stumbles upon 90 per cent effective ‘sugar-coating’ methodMayo Clinic scientists have made a breakthrough in type 1 diabetes treatment. They discovered a 'sugar coating' method. This protects insul...
Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...
How a 14-year-old’s medical treatment in 1922 revolutionized diabetes care and led to a historic four-way Nobel Prize splitThe invention of insulin in 1922 marked a turning point in medical history. Sparked by Frederick Banting’s idea and tested on diabetic pati...
Chinese scientists develop cure for diabetes, insulin patient becomes medicine-free in just 3 monthsChinese scientists achieve diabetes cure through innovative cell therapy, detailed in Cell Discovery. Patient, treated in July 2021, no lon...
No more insulin injection for diabetics? New capsule gives hopeAustralian scientists have designed a new type of oral capsule that could one day mean pain-free delivery of insulin and other protein drug...
Being overweight ups risk of diabetes. New study explains why and tips to delay the onsetThe findings have been published in the journal Cell Metabolism.
Biocon Biologics to partner with International Diabetes FederationGlobal Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:"Given our extensive experience in providing affordable insul...
Forget painful needle pricks, our body may cure diabetes itself in futureResearchers have identified cells that can take over functions of damaged or missing insulin-producing cells.
- Sea-snail venom holds key to diabetes medication
Melbourne, Sep 13 (IANS) The venom of a carnivorous sea snail could hold the key for artificial, fast-acting insulin for diabetes patients,...
Potential biomarker for pre-diabetes discoveredResearchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type 2 diabetes.
Indian scientists develop insulin pill for diabeticsIndian scientists have developed a long-sought insulin pill that could spare millions of diabetics around the world the pain of daily jabs.
- Biocon close to oral insulin deal with Bristol-Myers Squibb
Four months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
- We plan to expand clinical research in India: Novo Nordisk President and CEO
In an interview with ET, Novo Nordisk's president and CEO Lars Rebien Sorensen talks of the growing transfer of accounting and patenting wo...
- Clinical trials for oral insulin to enter phase two: Biocon
After the success of its recomibant human insulin "Insugen", Biocon said clinical trials for the oral insulin would soon enter phase two.
- Wockhardt in talks to out-license research molecules
Wockhardt is likely to out-license some of its research molecules to global pharma companies.